Skip to content

Clinical trials

Terminated Phase 1 Rectal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Phase 1 Status: Terminated Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20041
20062
20071
20093
20107
20131
20142
20163
20171
20181
20192
20203
20211
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)8
Case Comprehensive Cancer Center2
Fox Chase Cancer Center2
Novartis Pharmaceuticals2
University of Iowa2
Accent Therapeutics1
Cancer Research UK1
Craig L Slingluff, Jr1
Gilead Sciences1
Ludwig Institute for Cancer Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms37
Colonic Neoplasms25
Colorectal Neoplasms13
Carcinoma, Non-Small-Cell Lung6
Breast Neoplasms4
Lung Neoplasms4
Pancreatic Neoplasms4
Stomach Neoplasms4
Neoplasm Metastasis3
Breast Neoplasms, Male2

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.